Aceragen, Inc. (ACGN) vs aTyr Pharma, Inc. (ATYR)
- Aceragen, Inc. ACGN
- aTyr Pharma, Inc. ATYR 0.17 −5.56%
Aceragen, Inc. and aTyr Pharma, Inc. are both Biotechnology companies. Aceragen, Inc. and aTyr Pharma, Inc. are of similar size ($18.0M and $17.1M). Aceragen, Inc. grew revenue faster over the last twelve months: 1,226.3% against 6.78%. aTyr Pharma, Inc. has the higher net margin (0.00% vs −467.5%) and the higher return on invested capital (0.00% vs −135.4%). Across the 18 metrics below, aTyr Pharma, Inc. leads on 11 and Aceragen, Inc. on 7.
Valuation
Profitability
| Metric | ACGN | ATYR | Biotechnology median |
|---|---|---|---|
| Gross margin | 83.46% | 1.72% | 65.16% |
| Operating margin | (503.92%) | 0.00% | 0.00% |
| Net margin | (467.53%) | 0.00% | 0.00% |
| Free cash flow margin | (339.17%) | 0.00% | 0.00% |
| Return on equity | (169.66%) | (98.67%) | (56.36%) |
| Return on assets | (75.58%) | (70.97%) | (48.04%) |
| Return on invested capital | (135.35%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack